Document Type : Original Article


1 Department of Nursing and Midwifery, Neyshabur University of Medical Sciences, Neyshabur, Iran

2 PhD Candidate in Reproductive Health, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Isfahan University of Medical Sciences, Isfahan, Iran

3 PhD Candidate in Reproductive Health, Department of Midwifery, Faculty of Medicine, Social Development and Health Promotion Research Center, Gonabad University of Medical Sciences, Gonabad, Iran


BACKGROUND: Candidiasis vaginitis is an opportunistic and common mucosal infection. Although
Candida albicans is the most common isolated species, other species of Candida such as Candida
glabrata, Candida krusei, Candida parapsilosis, and Candida tropicalis have also increased
significantly in recent years. The aim of this study was to identify Candida species in women with
candidal vaginal infection in order to promote health in women.
MATERIALS AND METHODS: This cross‑sectional descriptive study was performed on nonpregnant
women of childbearing age who referred to health centers in Neyshabur in 2018. At the beginning of
the study, 163 people entered the study and the culture results were positive in 68 of them. In vitro,
culture was performed in subduxtrose agar medium containing chloramphenicol and gentamicin.
Species identification was performed using Candida specific culture medium (Saburo dextrose agar
and chloramphenicol). After culture, 15% of the residual wet slide with potash (KOH) was prepared
and observed with a lens. Finally, the data were analyzed with SPSS software version 24.
RESULTS: The participants in the study were women with a mean age of 35.55 ± 5.47 and the
average number of deliveries was 1.38 ± 1.15. In this study, the prevalence of C. albicans was
59.7%, C. tropicalis was 14.8%, C. krusei was 15%, and C. glabrata was 7.61% and also krusei and
tropicalis were 3% simultaneously. Therefore, C. albicans was the most common species isolated
from clinical specimens.
CONCLUSION: In this study, the most common species after albicans were C. tropicalis and
cruciferous. Considering the role of C. glabrata in the development of resistance to antifungal drugs,
the lower prevalence of this species in the present study can be associated with improved treatment
outcomes in patients.


1. Ahangari F, Farshbaf‑Khalili A, Javadzadeh Y, Adibpour M,
Sadeghzadeh Oskouei B. Comparing the effectiveness of Salvia
officinalis, clotrimazole and their combination on vulvovaginal
candidiasis: A randomized, controlled clinical trial. J Obstet
Gynaecol Res 2019;45:897‑907.
2. Berek JS. In: Gj B, editor. Berek and Novak’s Gynecology. LWW;
16th edition. 2019.
3. Donders GG, Ravel J, Vitali B, Netea MG, Salumets A, Unemo M.
Role of molecular biology in diagnosis and characterization
of vulvo‑vaginitis in clinical practice. Gynecol Obstet Invest
4. Rajabibazl M, Javad Rasaee M, Nouri Fard M, Farahnejad Z.
Development of agglutination test for detection of isolated
mannoprotein antigen from Candida albicans. J Army Univ
5. Nozari S, Moghaddam AS, Khoshdel A, Noorifard M,
Moosavi AA. Geographic information system of fungal disease
of Iran. J Army Univ 2013;11:357‑74.
6. van der Meijden WI, Boffa MJ, Ter Harmsel WA, Kirtschig G,
Lewis FM, Moyal‑Barracco M, et al. 2016 European guideline
for the management of vulval conditions. J Eur Acad Dermatol
Venereol 2017;31:925‑41.
7. Aguirre‑Quiñonero A, Castillo‑Sedano IS, Calvo‑Muro F,
Canut‑Blasco A. Accuracy of the BD MAX™ vaginal panel in the
diagnosis of infectious vaginitis. Eur J Clin Microbiol Infect Dis
8. Swidsinski A, Guschin A, Tang Q, Dörffel Y, Verstraelen H,
Tertychnyy A, et al. Vulvovaginal candidiasis: Histologic lesions
are primarily polymicrobial and invasive and do not contain
biofilms. Am J Obstet Gynecol 2019;220:91.e1‑91.e8.
9. Moallaie H, Verissimo C, Brando J, Rosado L. The sensitivity
and resistance of Yeasts isolated from women with vulvovaginal
Candidiasis to common antifungal drugs using disc diffusion.
Open Aire 2010;16:213‑9.
10. Nazeri M, Mesdaghinia E, Moravej SA, Atabakhshiyan R,
Soleymani F. Prevalence of vulvovaginal candidiasis and
frequency of candida species in women. J Mazandaran Univ Med
Sci 2012;21:254‑62.
11. Khorsand I, Ghanbari Nehzag MA, Zarrinfar H, Fata A, Naseri A,
Badiee P, et al. Frequency of variety of Candida species in women
with Candida vaginitis referred to clinical centers of Mashhad,
Iran. IJOGI 2015;18:15‑22.
12. Janani FA, Delfan B, Toulabi T, Ebrahim Zadeh F, Motamedi M.
A Comparative study of effect of myrtus vaginal cream and
clotrimazol vaginal cream in the treatment of vaginal candidiasis.
Sci Mag Yafte 2011;13:32‑41.
13. Molaeinezhad M, Khoei EM, Salehi M, Yousfy A, Roudsari RL.
Validation of the partner version of the multidimensional vaginal
penetration disorder questionnaire: A tool for clinical assessment
of lifelong vaginismus in a sample of Iranian population. J Educ
Health Promot 2014;3:114.
14. Baradaran‑Akbarzadeh N, Tafazoli M, Mojahedi M, Mazlom SR.
The effect of educational package on sexual function in cold
temperament women of reproductive age. J Educ Health Promot
15. BuscemiL, ArechavalaA, NegroniR. Study of acute vulvovaginitis
in sexually active adult women, with special reference to
candidosis, in patients of the Francisco J. Muñiz Infectious
Diseases Hospital. Rev Iberoam Micol 2004;21:177‑81.
16. Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G,
Kouskouni E. Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur J Obstet Gynecol
Reprod Biol 2006;126:121‑5.
17. Aali B, Tohidi A. Prevalence of candida vaginits among
symptomatic patients in kerman. Journal of Inflammatory
Diseases 2000;4 :42-8.
18. Mahmodirad MZ, Amiri Z, Shivai M, Amel M. Prevalence of
Candida species in vaginal candidiasis findings referred to
Mahdie hospitals in 87‑88. J Facult Med 2011;33:189‑94.
19. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ,
Pfaller MA. Antifungal susceptibilities of Candida species causing
vulvovaginitis and epidemiology of recurrent cases. J Clin
Microbiol 2005;43:2155‑62.
20. Odds FC, Bernaerts R. CHROMagar Candida, a new differential
isolation medium for presumptive identification of clinically
important Candida species. J Clin Microbiol 1994;32:1923‑9.
21. De Pádua RF, Guilhermetti E, Svidzinski TE. In vitro activity of
antifungal agents on yeasts isolated from vaginal secretion. Acta
Sci 2003;25:51‑4.
22. Fan SR, Liu XP, Li JW. Clinical characteristics of vulvovaginal
candidiasis and antifungal susceptibilities of Candida species
isolates among patients in southern China from 2003 to 2006.
J Obstet Gynaecol Res 2008;34:561‑6.
23. Abu‑Elteen KH. Increased incidence of vulvovaginal candidiasis
caused by Candida glabrata in Jordan. Jpn J Infect Dis 2001;54:103‑7.
24. Kunzelmann V, Tietz HJ, Rossner D, Czaika V, Hopp M,
Schmalreck A, et al. Prerequisites for effective therapy of chronic
recurrent vaginal candidiasis. Mycoses 1996;39 Suppl 1:65‑72.
25. Willinger B, Manafi M. Evaluation of CHROMagar Candida
for rapid screening of clinical specimens for Candida species.
Mycoses 1999;42:61‑5.